Suppr超能文献

降钙素基因相关肽和P物质作为盆腔静脉疼痛的预测指标

Calcitonin Gene-Related Peptide and Substance P As Predictors of Venous Pelvic Pain.

作者信息

Gavrilov S G, Vasilieva G Yu, Vasiliev I M, Efremova O I

机构信息

Pirogov Russian National Research Medical University, Moscow, 119049 Russia.

Institute of Bio-Medical Problems, Russian Academy of Sciences, Moscow, 123007 Russia.

出版信息

Acta Naturae. 2019 Oct-Dec;11(4):88-92. doi: 10.32607/20758251-2019-11-4-88-92.

Abstract

The purpose of this work was to study the contents of calcitonin gene-related peptide (CGRP) and substance P (SP) in the blood plasma of patients with pelvic varicose veins. Thirty women with pelvic varicosities and a reflux blood flow were investigated using duplex ultrasonography. Group 1 included 18 patients with clinical signs of the pelvic congestion syndrome (PCS), including venous pelvic pain (VPP). Group 2 consisted of 12 patients with pelvic varicosities with no clinical signs of PCS. The score of VPP intensity ranged from 4 to 8; the mean score being 4.84 ± 0.43. The CGRP level in the studied group ranged from 0.39 to 1.01 ng/mL; the SP level ranged from 0.005 to 1.33 ng/mL. . The CGRP values were 0.15-0.32 ng/mL, and the SP range was 0.003-0.3 ng/mL. In this group, the levels of the studied peptides were 3-5 times lower than those for the patients with VPP. The mean CGRP values were 0.06 ± 0.003 ng/mL, and the mean SP values were 0.03 ± 0.001 ng/mL. These values were considered as the reference parameters; a statistical analysis was performed for them. The correlation analysis revealed a strong relationship between the CGRP and VPP levels (r = 0.82) and a medium correlation between the SP level and pelvic pain in Group 1. The CGRP and SP levels in blood plasma highly correlate with the presence of pelvic venous pain.

摘要

本研究旨在探讨盆腔静脉曲张患者血浆中降钙素基因相关肽(CGRP)和P物质(SP)的含量。对30例存在盆腔静脉曲张且有反流血流的女性患者进行了双功超声检查。第1组包括18例有盆腔充血综合征(PCS)临床症状的患者,包括盆腔静脉疼痛(VPP)。第2组由12例无PCS临床症状的盆腔静脉曲张患者组成。VPP强度评分范围为4至8分;平均评分为4.84±0.43分。研究组中CGRP水平范围为0.39至1.01 ng/mL;SP水平范围为0.005至1.33 ng/mL。CGRP值为0.15 - 0.32 ng/mL,SP范围为0.003至0.3 ng/mL。在该组中,所研究肽类的水平比VPP患者低3至5倍。CGRP的平均数值为0.06±0.003 ng/mL,SP的平均数值为0.03±0.001 ng/mL。这些数值被视为参考参数,并对其进行了统计分析。相关性分析显示,CGRP与VPP水平之间存在强相关性(r = 0.82),第1组中SP水平与盆腔疼痛之间存在中度相关性。血浆中的CGRP和SP水平与盆腔静脉疼痛的存在高度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c114/6977958/ed7af389c162/AN20758251-11-04-088-g001.jpg

相似文献

1
Calcitonin Gene-Related Peptide and Substance P As Predictors of Venous Pelvic Pain.
Acta Naturae. 2019 Oct-Dec;11(4):88-92. doi: 10.32607/20758251-2019-11-4-88-92.
2
Hemodynamic and neurobiological factors for the development of chronic pelvic pain in patients with pelvic venous disorder.
J Vasc Surg Venous Lymphat Disord. 2023 May;11(3):610-618.e3. doi: 10.1016/j.jvsv.2023.01.006. Epub 2023 Feb 11.
4
[Neurobiological aspects of venous pelvic pain].
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(11):74-79. doi: 10.17116/jnevro201911911174.
5
Does pelvic congestion syndrome influence symptoms of chronic venous disease of the lower extremities?
Eur J Obstet Gynecol Reprod Biol. 2019 Dec;243:83-86. doi: 10.1016/j.ejogrb.2019.10.025. Epub 2019 Oct 22.
6
Surgical aspects of venous pelvic pain treatment.
Curr Med Res Opin. 2019 Nov;35(11):1983-1989. doi: 10.1080/03007995.2019.1631059. Epub 2019 Jul 16.

引用本文的文献

1
Hemodynamic and neurobiological factors for the development of chronic pelvic pain in patients with pelvic venous disorder.
J Vasc Surg Venous Lymphat Disord. 2023 May;11(3):610-618.e3. doi: 10.1016/j.jvsv.2023.01.006. Epub 2023 Feb 11.
3
Relationships of Pelvic Vein Diameter and Reflux with Clinical Manifestations of Pelvic Venous Disorder.
Diagnostics (Basel). 2022 Jan 7;12(1):145. doi: 10.3390/diagnostics12010145.
4
Comprehensive overview of the venous disorder known as pelvic congestion syndrome.
Ann Med. 2022 Dec;54(1):22-36. doi: 10.1080/07853890.2021.2014556.
5
CGRP measurements in human plasma - a methodological study.
Cephalalgia. 2021 Nov;41(13):1359-1373. doi: 10.1177/03331024211024161. Epub 2021 Jul 16.

本文引用的文献

1
The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects.
Front Physiol. 2018 Sep 19;9:1249. doi: 10.3389/fphys.2018.01249. eCollection 2018.
2
Pelvic vein incompetence: clinical perspectives.
Vasc Health Risk Manag. 2017 Nov 27;13:439-447. doi: 10.2147/VHRM.S132827. eCollection 2017.
3
Calcitonin gene-related peptide and pain: a systematic review.
J Headache Pain. 2017 Dec;18(1):34. doi: 10.1186/s10194-017-0741-2. Epub 2017 Mar 16.
5
Is pelvic vein incompetence associated with symptoms of chronic pelvic pain in women? A pilot study.
Eur J Obstet Gynecol Reprod Biol. 2016 Jan;196:21-5. doi: 10.1016/j.ejogrb.2015.10.023. Epub 2015 Nov 25.
7
Ovarian Vein Diameter Cannot Be Used as an Indicator of Ovarian Venous Reflux.
Eur J Vasc Endovasc Surg. 2015 Jan;49(1):90-4. doi: 10.1016/j.ejvs.2014.10.013.
8
Pelvic congestion syndrome: etiology of pain, diagnosis, and clinical management.
J Vasc Interv Radiol. 2014 May;25(5):725-33. doi: 10.1016/j.jvir.2014.01.030.
9
Using magnetic resonance phase-contrast velocity mapping for diagnosing pelvic congestion syndrome.
Phlebology. 2011 Jun;26(4):157-61. doi: 10.1258/phleb.2010.010049.
10
Increased expression of endothelin-1 and its receptors in varicocele: an immunohistochemical study.
Fertil Steril. 2011 Jun 30;95(8):2554-6.e1-2. doi: 10.1016/j.fertnstert.2011.04.062. Epub 2011 May 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验